Meds, Mind, Body & Benefits > Research News & Studies

Long term treatment


This kind of fits in with the post Jim made concerning long term PrEP here.

Gilead Science and Merck teaming up to work on long term injection treatment and oral treatment dosed once a week or once a month. Utilising lenacapavir from Gilead and Islatravir from Merck. Good to rival companies joining forces on this.


[0] Message Index

Go to full version